|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA A
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar
|
|
2
|
Menon U: Ovarian cancer: challenges of
early detection. Nat Clin Pract Oncol. 4:498–499. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi C, Qin L, Gao H, Gu L, Yang C, Liu H
and Liu T: NUCKS nuclear elevated expression indicates progression
and prognosis of ovarian cancer. Tumour Biol.
39:10104283177146312017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen
X, Zhang Q, Yan G and Cui Q: LncRNADisease: A database for
long-non-coding RNA-associated diseases. Nucleic Acids Res.
41:D983–D986. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu H, Lv Z and Guo E: Knockdown of long
noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation,
metastasis and epithelial-mesenchymal transition. Int J Clin Exp
Pathol. 8:9140–9146. 2015.PubMed/NCBI
|
|
8
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang Y, Li H, Hou S, Hu B, Liu J and Wang
J: The noncoding RNA expression profile and the effect of lncRNA
AK126698 on cisplatin resistance in non-small-cell lung cancer
cell. PLoS One. 8:e653092013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 LncRNA
antagonizes Let-7 MicroRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang R, Jin H and Lou F: The long
non-coding RNA TP73-AS1 interacted with miR-142 to modulate brain
glioma growth through HMGB1/RAGE pathway. J Cell Biochem.
119:3007–3017. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zang W, Wang T, Wang Y, Chen X, Du Y, Sun
Q, Li M, Dong Z and Zhao G: Knockdown of long non-coding RNA
TP73-AS1 inhibits cell proliferation and induces apoptosis in
esophageal squamous cell carcinoma. Oncotarget. 7:19960–19974.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang SZ, Pan FY, Xu JF, Yuan J, Guo SY,
Dai G, Xue B, Shen WG, Wen CJ, Zhao DH and Li CJ: Knockdown of
c-Met by adenovirus-delivered small interfering RNA inhibits
hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer
Ther. 4:1577–1584. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fang Z, Zhang L, Liao Q, Wang Y, Yu F,
Feng M, Xiang X and Xiong J: Regulation of TRIM24 by miR-511
modulates cell proliferation in gastric cancer. J Exp Clin Cancer
Res. 36:172017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA A Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar
|
|
17
|
Puvanenthiran S, Essapen S, Seddon AM and
Modjtahedi H: Impact of the putative cancer stem cell markers and
growth factor receptor expression on the sensitivity of ovarian
cancer cells to treatment with various forms of small molecule
tyrosine kinase inhibitors and cytotoxic drugs. Int J Oncol.
49:1825–1838. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dillman RO, McClay EF, Barth NM, Amatruda
TT, Schwartzberg LS, Mahdavi K, de Leon C, Ellis RE and DePriest C:
Dendritic versus tumor cell presentation of autologous tumor
antigens for active specific immunotherapy in metastatic melanoma:
Impact on long-term survival by extent of disease at the time of
treatment. Cancer Biother Radiopharm. 30:187–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zou Z, Zou R, Zong D, Shi Y, Chen J, Huang
J, Zhu J, Chen L, Bao X, Liu Y, et al: miR-495 sensitizes MDR
cancer cells to the combination of doxorubicin and taxol by
inhibiting MDR1 expression. J Cell Mol Med. 21:1929–1943. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang YW, Cheng HL, Ding YR, Chou LH and
Chow NH: EMP1, EMP 2 and EMP3 as novel therapeutic targets in human
cancer. Biochim Biophys Acta. 1868:199–211. 2017.PubMed/NCBI
|
|
21
|
Eccleston A, Bentley A, Dyer M, Strydom A,
Vereecken W, George A and Rahman N: A cost-effectiveness evaluation
of germline BRCA1 and BRCA2 testing in UK women with ovarian
cancer. Value Health. 20:567–576. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan H, Xia JY and Feng FZ: Long non-coding
RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian
cancer cells. Genet Mol Res. 16:2017.doi: 10.4238/gmr16019411.
View Article : Google Scholar
|
|
23
|
Liu RT, Cao JL, Yan CQ, Wang Y, An CJ and
Lv HT: Effects of LncRNA-HOST2 on cell proliferation, migration,
invasion and apoptosis of human hepatocellular carcinoma cell line
SMMC-7721. Biosci Rep. 37:BSR201605322017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu R, Zeng Y, Zhou CF, Wang Y, Li X, Liu
ZQ, Chen XP, Zhang W and Zhou HH: Long noncoding RNA expression
signature to predict platinum-based chemotherapeutic sensitivity of
ovarian cancer patients. Sci Rep. 7:182017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li H, Liu C, Lu Z, Chen L, Wang J, Li Y
and Ma H: Upregulation of the long non-coding RNA SPRY4-IT1
indicates a poor prognosis and promotes tumorigenesis in ovarian
cancer. Biomed Pharmacother. 88:529–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zuo ZK, Gong Y, Chen XH, Ye F, Yin ZM,
Gong QN and Huang JS: TGFβ1-induced LncRNA UCA1 upregulation
promotes gastric cancer invasion and migration. DNA Cell Biol.
36:159–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou C, Huang C, Wang J, Huang H, Li J,
Xie Q, Liu Y, Zhu J, Li Y, Zhang D, et al: LncRNA MEG3
downregulation mediated by DNMT3b contributes to nickel malignant
transformation of human bronchial epithelial cells via modulating
PHLPP1 transcription and HIF-1α translation. Oncogene.
36:3878–3889. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang CL, Zhu KP and Ma XL: Antisense
lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by
increasing the expression of FOXC2. Cancer Lett. 396:66–75. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu H, Xue Y, Wang P, Liu X, Ma J, Zheng J,
Li Z, Li Z, Cai H and Liu Y: Knockdown of long non-coding RNA XIST
increases blood-tumor barrier permeability and inhibits glioma
angiogenesis by targeting miR-137. Oncogenesis. 6:e3032017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiong H, Ni Z, He J, Jiang S, Li X, He J,
Gong W, Zheng L, Chen S, Li B, et al: LncRNA HULC triggers
autophagy via stabilizing Sirt1 and attenuates the chemosensitivity
of HCC cells. Oncogene. 36:3528–3540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kuang D, Zhang X, Hua S, Dong W and Li Z:
Long non-coding RNA TUG1 regulates ovarian cancer proliferation and
metastasis via affecting epithelial-mesenchymal transition. Exp Mol
Pathol. 101:267–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al:
A functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu E, Liu Z, Zhou Y, Mi R and Wang D:
Overexpression of long non-coding RNA PVT1 in ovarian cancer cells
promotes cisplatin resistance by regulating apoptotic pathways. Int
J Clin Exp Med. 8:20565–20572. 2015.PubMed/NCBI
|
